302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors. (September 2015) - Italiano, A.; Keilhack, H.; Toulmonde, M.; Coindre, J.M.; Michot, J.M.; Massard, C.; Ottesen, L.; Reyderman, L.; Blakemore, S.J.; Kraljevic, S.; Thomson, B.; McDonald, A.; et al.